Last updated on May 2019

XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Disease | Coronary heart disease
  • Age: Between 19 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 19 and more
  • Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent
  • Agreed with written informed consent form

Exclusion Criteria:

  • Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.